The month of April was kind to the Healthcare Model. Strategies Model benefits from strong healthcare gains
Sequenom appreciated 11.2% contributing a great deal to the portfolio's performance. Strategies Why we added biotech stock Sequenom to the lineup
2011 was a challenging year for investors, and for the Healthcare model it was particularly difficult. Strategies Healthcare investing in an election year
Covestor manager Robert Freedland comments on the big August 2011 downturn. Strategies It’s one thing to exit the market, quite another to …
Covestor manager Bob Freedland comments on the market's recent big downturn. Strategies I’m reducing these positions following the steep correction – Bob …